Atlas Trials

A Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC

Clinical trial NCT05212922 · WITHDRAWN

Trial details

NCT number
NCT05212922
Sponsor
Eucure (Beijing) Biopharma Co., Ltd
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
HCCNSCLC Stage IIIBNSCLC Stage IV
Start date
2023-06-01
Primary completion
2024-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.